Nilogen Oncosystems’ Post

Nilogen Oncosystems

2,323 followers

11mo

Rikhia Chakraborty

Chief Scientific Officer @ Nilogen Oncosystems | Cancer Biology PhD

11mo

I’m happy to share that I’m starting a new position as Chief Scientific Officer at Nilogen Oncosystems!

This content isn’t available here

Access this content and more in the LinkedIn app

2 Comments

Nilogen Oncosystems

11mo

Congratulations! Glad to have you lead our scientific team to help us fulfill our vision to make cancer treatments more effective, accessible, and affordable for the patients we serve.

1 Reaction

Shilpa Kadam

Translation Medicine Lead: Cell Therapy, Biologics, Small Molecules

11mo

Congratulations. Looking forward to working together

1 Reaction

See more comments

To view or add a comment, sign in

More Relevant Posts

Nilogen Oncosystems

2,323 followers
1mo
Report this post
Make this summer a season of discovery with Nilogen’s 3D ex vivo technology. Get rapid, actionable results and accelerate your journey from discovery to clinical application. For more information, visit www.nilogen.com or contact us at BD@nilogen.com.
Like Comment
To view or add a comment, sign in
Nilogen Oncosystems

2,323 followers
2mo
Report this post
Join us for a special LinkedIn Live interview on June 19 at 9 am PDT with Rikhia Chakraborty, Nilogen Oncosystems’ CSO. Explore the forefront of cancer technology with insights into our tumoroid platforms and discover how Nilogen is shaping the future of immuno-oncology, improving clinical outcome predictability. In conversation with Hersh Ashish Chaturvedi, VP with Strategic Partnerships, we will dive into the complexities of maintaining the tumor microenvironment and harnessing AI in biomedical research. Save the date and don't miss this exclusive opportunity to learn about the cutting-edge technologies in cancer research! #NilogenOncosystems #CancerResearch #Immunotherapy #BiomedicalInnovation #LinkedInLive #HealthcareTechnology #Tumoroidplatforms https://lnkd.in/gWN6btdp

Infinita Lab

6,675 followers
2mo Edited

Join us for an exclusive LinkedIn Live interview on June 19 at 9 am PDT with Rikhia Chakraborty, a leading expert from Nilogen Oncosystems. Rikhia will delve into the cutting-edge technologies revolutionizing cancer research, including their innovative use of tumoroid platforms and high throughput testing. Discover how Nilogen’s pioneering approaches are enhancing the predictability of clinical outcomes and transforming immuno-oncology. This insightful conversation with Hersh Ashish Chaturvedi, our VP - Strategic Partnerships, will explore the challenges and breakthroughs in maintaining the tumor microenvironment and leveraging AI in biomedical research. Don't miss this opportunity to gain valuable insights into the future of cancer therapy. Mark your calendars and join us live! #linkedinlive #biotechnology #tumorresearch #infinitalab

Ex Vivo Approaches to Cancer Treatment Development & Screening

www.linkedin.com
Like Comment
To view or add a comment, sign in
Nilogen Oncosystems

2,323 followers
2mo Edited
Report this post
We're thrilled to announce our participation at ASCO 2024! Visit us at Booth #35094 to discover why our advanced tumoroid platform is revolutionizing preclinical studies. 🔬 Why Tumoroids? Tumoroids offer a cutting-edge alternative to traditional 3D systems, providing more realistic models that closely mimic human cancer environments. This leap in technology enables more accurate and predictive analyses, setting a new standard for oncology research. 🤝 Meet Our Experts: Drop by to chat with our representatives William Coward, Jared Ehrhart, and Carlo Petruzziello. They're eager to share insights and discuss how Nilogen's innovative solutions can accelerate your research. Don't miss the opportunity to learn about the future of preclinical studies with us at ASCO 2024. See you there! #ASCO2024
Like Comment
To view or add a comment, sign in
Nilogen Oncosystems

2,323 followers
4mo
Report this post
#AACR2024 #nilogenoncosystems #exvivotumormodel POSTER NUMBER #6782
Abhinit Nagar, M.Sc., Ph.D.

Immunologist | Microscopy and Flow Cytometry Expert | High-Throughput Solutions for Life Sciences | Developed ICCE (First high through-put imaging based inflammasome evaluation assay)
4mo

Visit our poster at section 6 poster board 20 to explore the intricacies of our state-of-the-art technology and gain insights into leveraging tumoroids for your experiments. Discover cutting-edge methodologies and techniques to optimize your research endeavors. Meet with Rikhia Chakraborty and Jared Ehrhart and learn more about our tumor model platforms. Nilogen Oncosystems #AACR2024
Like Comment
To view or add a comment, sign in
Nilogen Oncosystems

2,323 followers
5mo
Report this post
Exciting news! Nilogen Oncosystems is thrilled to announce our presence at AACR 2024! 🎉 We cordially invite you to visit our booth to discover more about our groundbreaking advancements in oncology research. Learn firsthand about our innovative approaches and cutting-edge solutions aimed at revolutionizing cancer therapeutics. Don't miss this opportunity to engage with our team and explore the future of oncology. See you there! #AACR2024 #OncologyResearch #3dcancermodel #precisiononcology #NilogenOncosystems
Like Comment
To view or add a comment, sign in

2,323 followers

View Profile Follow

Nilogen Oncosystems’ Post

More Relevant Posts

Ex Vivo Approaches to Cancer Treatment Development & Screening

www.linkedin.com

Explore topics